Professor Lex Wunderink

Professor Lex Wunderink (Netherlands)
Lex Wunderink, psychiatrist (1954) is head of the Department of Education and Research and director of psychiatric residency training at Friesland Mental Health Services, Leeuwarden, and working at the Rob Giel Research Center, Groningen University Medical Center, The
Netherlands. He recently conducted the Medication Strategies in First Onset Schizophrenia (MESIFOS) trial comparing outcomes of targeted and maintenance treatment strategy in remitted first episode psychosis. He was trained as a psychiatrist at Rotterdam University Hospital (1982). In the early nineties he initiated one of the first assertive community treatment services for severely mentally ill people in the Netherlands, inspired by the Madison model. He was director of psychiatric residency training at the Dordrecht Mental Health Services until he moved to Groningen University in 2001. He is currently involved in research into the risk factors of ultra high risk youth and first episode patients and the implementation of a youth at risk program. He is also engaged in research on the effectiveness of care for SMI patients, and carrying out a trial comparing ACT vs ACT plus evidence based interventions.